TABLE 3.

Adjusted effects of the platelet count/spleen thickness ratio on rebleeding within one year in cirrhotic patients with moderate or severe.

Platelet count/Spleen thickness ratio	Odds ratios of variceal rebleeding (N = 565) (95% CI), P-value
	Unadjusted	Adjusted*
Continuous	0.56 (0.44–0.70) <0.001	0.53 (0.42–0.67) <0.001
Quartiles
Q4: > 1.98	1.00 (reference)	1.00 (reference)
Q3: (1.36–1.98]	1.36 (0.72–1.99) 0.503	1.08 (0.63–1.53) 0.768
Q2: (1.01–1.36]	1.99 (1.25–2.74) 0.032	1.46 (1.15–1.78) 0.039
Q1: ≤ 1.01	2.34 (1.28–3.61) < 0.001	2.01 (1.22–2.81) 0.006

*Adjusted for age, gender, and etiology of cirrhosis, aspartate aminotransferase, alanine aminotransferase, hemoglobin, platelet, international normalized ratio, model for end-stage liver disease, red color sign of EGV, portal vein thrombosis, and esophagogastric varices grade. 95% CI, confidence interval.